SpringerLink
Log in

VIP as a cell-growth and differentiation neuromodulator role in neurodevelopment

  • Proceedings of the Satellite of the 14th ISN Meeting and the First International Workshop entitled The Neuronal Phenotype Molecular Biology, Cell Specification, and Therapeutic Frontiers held in Lozari, Corsica, France, August 19–20, 1993
  • Published:
Molecular Neurobiology Aims and scope Submit manuscript

Abstract

In addition to its commonly recognized status as a neuromodulator of virtually all vital functions, including neurobiological., the neuropeptide VIP plays a role in the control of cell growth and differentiation and of neuronal survival. Through, these actions, VIP, whose impact appears early in ontogeny, may possess developmental functions. VIP can be stimulatory or inhibitory on cell growth in function of the model considered. The growth regulatory actions of VIP, which are often independent of cAMP, are most likely significant when mitogenic or trophic factors, eventually released by nontarget cells, are simultaneously present in the extracellular medium. The intracellular mechanisms that mediate these actions of VIP may involve different transduction cascades triggered by subsets of VIP binding sites that may coexist in the same tissue.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Agoston D. V., Eiden L. E., Brenneman D. E., and Gozes I. (1991) Spontaneous electrical activity regulates vasoactive intestinal peptide expression in dissociated spinal cord cultures.Mol. Brain Res. 10, 235–240.

    Article  PubMed  CAS  Google Scholar 

  • Alberts H. E., Stopa E. G., Zoeller R. T., Kauer J. S., King J. C., Fink J. S., et al. (1990) Day-night variation in prepro VIP/PHI mRNA within the suprachiasmatic nucleus.Mol. Brain Res. 7, 85–89.

    Article  Google Scholar 

  • Arimura A. (1992) Pituitary adenylate cyclase activating polypeptide (PACAP): discovery and current status of research.Regul. Pept. 37, 287–303.

    PubMed  CAS  Google Scholar 

  • Audigier S., Barberis C., and Jard S. (1988) Vasoactive intestinal polypeptide increases inositol phosphate breakdown, in the rat superior cervical ganglion.Ann. NY Acad. Sci. 527, 579–581.

    Article  Google Scholar 

  • Bardrum B., Ottesen B., Fahrenkrug J., and Fuchs A. R. (1988) Release of oxitocin and vasopressin by intraventricular vasoactive intestinal peptide.Endocrinology 123, 2249–2254.

    PubMed  CAS  Google Scholar 

  • Beinfeld M. C., Brick P. L., Howlett A. C., Lee Holt I., Pruss R. M., Moskal J. R., et al. (1988) The regulation of vasoactive intestinal peptide synthesis in neuroblastoma and chromaffin cells.Ann. NY Acad. Sci. 527, 68–76.

    Article  PubMed  CAS  Google Scholar 

  • Berthon P., Mirossay L., Empereur S., Chastre E., De Cremoux P., Calvo F., et al. (1992) VIP receptor activity and signal transduction in the cancerous progression of the mammary epithelium.Biomed. Res. 13 S2, 169–180.

    Google Scholar 

  • Bissonnette B. M., Collen M. J., Adachi H., Jensen R. T., and Gardner J. D. (1984) Receptors for vasoactive intestinal peptide and secretin on rat pancreatic acini.Am. J. Physiol. 246, G710-G717.

    PubMed  CAS  Google Scholar 

  • Bon C., Böhme G. A., Doble A., Stutzmann J. M., and Blanchard J. C. (1992) A role for nitric oxide in long-term potentiation.Eur. J. Neurosci. 4, 420–424.

    Article  PubMed  Google Scholar 

  • Boudard F. and Bastide M. (1991) Inhibition of mouse T-cell proliferation by CGRP and VIP: effects of these neuropeptides on IL2 production and cAMP synthesis.J. Neurosci. Res. 29, 29–41.

    Article  PubMed  CAS  Google Scholar 

  • Bredt D. S. and Snyder S. H. (1992) Nitric oxide, a novel neuronal messenger.Neuron 8, 3–11.

    Article  PubMed  CAS  Google Scholar 

  • Brenneman D. E., Eiden L. E., and Siegel R. E. (1985) Neurotrophic action of VIP on spinal cord cultures.Peptides 6, 35–39.

    Article  PubMed  CAS  Google Scholar 

  • Brenneman D. E. and Eiden L. E. (1986) Vasoactive intestinal peptide and electrical activity influence neuronal survival.Proc. Natl. Acad. Sci. USA 83, 1159–1162.

    Article  PubMed  CAS  Google Scholar 

  • Brenneman D. E., Neale E. A., Foster G. A., D'Autremont S., and Westbrook G. L. (1987) Non-neuronal cells mediate neurotrophic action of vasoactive intestinal peptide.J. Cell Biol. 104, 1603–1610.

    Article  PubMed  CAS  Google Scholar 

  • Brenneman D. E. (1988) Regulation of activitylinked neuronal survival by vasoactive intestinal peptide.Ann. NY Acad. Sci. 527, 595–597.

    Article  Google Scholar 

  • Brenneman D. E., Westbroock G. L., Fitzgerald S. P., Ennist D. L., Elkins K., Ruff M. R., et al. (1988) Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide.Nature 335, 639–642.

    Article  PubMed  CAS  Google Scholar 

  • Brenneman D. E., Nicol T., Warren D., and Bowes L. M. (1990) Vasoactive Intestinal Peptide: a neurotrophic releasing agent and an astroglial mitogen.J. Neurosci. Res. 25, 386–394.

    Article  PubMed  CAS  Google Scholar 

  • Brenneman D. E., Schulzberg M., Bartfai T., and Gozes I. (1992) Cytokine regulation of neuronal survival.J. Neurochem. 58, 454–460.

    Article  PubMed  CAS  Google Scholar 

  • Calderano V., Chiosi E., Greco R., Spina A. M., Giovane A., Quagliuolo L., et al. (1993) Role of calcium in chloride secretion mediated by cAMP pathway activation in rabbit distal colon mucosa.Am. J. Physiol. 264 G252-G260.

    Google Scholar 

  • Chelbi-Alix M. K., Boissard C., Sripati C. E., Rosselin G., and Thang M. N. (1991) VIP induces in HT-29 cells 2′5′ oligoadenylate synthetase and antiviral state via interferon α/β synthesis.Peptides 12, 1085–1093.

    Article  PubMed  CAS  Google Scholar 

  • Chelbi-Alix M. K., Brouard A., Boissard C., Pelaprat D., Rostene W., and Thang M. N. (1994) Induction by vasoactive intestinal peptide of interferon α/β synthesis in glial cells but not in neurons.J. Cell. Physiol. 158, 47–54.

    Article  PubMed  CAS  Google Scholar 

  • Chen Q., Chen Y. F., Sheng H. M., Hou X., Lu G. J., Luo W., et al. (1992) Autocrine regulatory effect of vasoactive intestinal peptide (VIP) on human pancreatic carcinoma cells.Biomed. Res. 13 S2, 225,226.

    Google Scholar 

  • Chick C. L., Ho A. K., and Klein D. C. (1988) α1-Adrenergic potentiation of vasoactive intestinal peptide stimulation of rat pinealocyte adenosine 3′,5′-monophosphate and guanosine 3′,5′-monophosphate: evidence for a role for calcium and protein kinase-C.Endocrinology 122, 702–708.

    Google Scholar 

  • Cholewinski A. J. and Wilkin G. P. (1988) Astrocytes from forebrain, cerebellum and spinal cord differ in their responses to vasoactive intestinal peptide.J. Neurochem. 51, 1626–1633.

    Article  PubMed  CAS  Google Scholar 

  • Cooper D. M. F. and Londos C. (1988)Receptor Biochemistry and Methodology, vol. 11., Adenosine Receptors, Liss, New York.

    Google Scholar 

  • Eckenstein F. and Baughman R. W. (1984) Two types of cholinergic innervation in cortex, one colocalized with vasoactive intestinal polypeptide.Nature 309, 153–155.

    Article  PubMed  CAS  Google Scholar 

  • Evans P. D. and Villegas J. (1988) The action of vasoactive intestinal peptide antagonists peptidergic modulation of the squid schwann cell.J. Exp. Biol. 138, 259–269.

    PubMed  CAS  Google Scholar 

  • Fahrenkrug J. (1992) Glycine-extended processing intermediate of proVIP: a new bioactive form of VIP in the rat.Biomed. Res. 13 S2, 19–24.

    Google Scholar 

  • Fatatis A., Holtzclaw L. A., Avidor R., Brenneman D. E., and Russell J. T. (1994) Vasoactive intestinal peptide increases intracellular calcium in astroglia: synergism with α-adrenergic receptors.Proc. Natl. Acad. Sci. 91, 2036–2040.

    Article  PubMed  CAS  Google Scholar 

  • Ferron A., Siggins G. R., and Bloom F. E. (1985) Vasoactive intestinal peptide acts synergistically with norepinephrine to depress spontaneous discharge rate in cerebral cortical neurons.Proc. Natl. Acad. Sci. USA 82, 8810–8812.

    Article  PubMed  CAS  Google Scholar 

  • Gafvelin G., Andersson M., Dimaline R., Jornvall H., and Mutt V. (1988) Isolation and characterization of a variant form of vasoactive intestinal polypeptide.Peptides 9, 469–474.

    Article  PubMed  CAS  Google Scholar 

  • Gamet L., Cazenave Y., Trocheris V., Denis-Pouxviel C., and Murat J. C. (1991) Involvement of ornithine decarboxylase in the control of proliferation of the HT29 human colon cancer cell line. Effect of vasoactive intestinal peptide on enzyme activity.Int. J. Cancer 47, 633–638.

    Article  PubMed  CAS  Google Scholar 

  • Gamet L., Murat J. C., Remaury A., Remesy C., Valet P., Paris H., et al. (1992) Vasoactive intestinal peptide and forskolin regulate proliferation of the HT29 human colon adenocarcinoma cell line.J. Cell. Physiol. 150, 501–509.

    Article  PubMed  CAS  Google Scholar 

  • Georg B., Wulff B. S., and Fahrenkrug J. (1992) Regulation of prepro-VIP expression in the human neuroblastoma cell line NB-1.Biomed. Res. 13 S2, 7–12.

    Google Scholar 

  • Girault J. A., Shalaby I. A., Rosen N. L., and Greengard P. (1988) Regulation by cAMP and vasoactive intestinal peptide of phosphorylation of specific proteins in striatal cells in culture.Proc. Natl. Acad. Sci. USA 85, 7790–7794.

    Article  PubMed  CAS  Google Scholar 

  • Gozes I., Bodner M., Shani Y., and Fridkin M. (1986) Structure and expression of the vasoactive intestinal peptide (VIP) gene in a human tumor.Peptides 7, 1–6.

    Article  PubMed  CAS  Google Scholar 

  • Gozes I., Avidor R., Katznelson D., Yahav Y., Croce C., and Hubner K. (1987a) The gene encoding vasoactive intestinal peptide is located on human chromosome 6p21-6qter.Hum. Genet. 75, 41–44.

    PubMed  CAS  Google Scholar 

  • Gozes I., Shani Y., and Rostene W. (1987b) Developmental expression of VIP-gene in rat brain and intestine.Mol. Brain Res. 2, 137–148.

    Article  CAS  Google Scholar 

  • Gozes I. (1988) Biosynthesis and regulation of expression: the vasoactive intestinal peptide gene.Ann. NY Acad Sci. 527, 77–86.

    Article  PubMed  CAS  Google Scholar 

  • Gozes, I., Shachter P., Shani Y., and Giladi E. (1988) Vasoactive intestinal peptide gene expression from embryos to aging rats.Neuroendocrinology 47, 27–31.

    PubMed  CAS  Google Scholar 

  • Gozes I. and Brenneman D. E. (1989) VIP: molecular biology and neurobiological function.Mol. Neurobiol. 3, 201–236.

    Article  PubMed  CAS  Google Scholar 

  • Gozes I., Davidson A., Draoui M., and Moody T. W. (1992) The VIP gene is expressed in non-small cell lung cancer cell lines.Biomed. Res. 13 S2, 37–40.

    Google Scholar 

  • Gozes I. and Brenneman D. E. (1993) Neuropeptides as growth and differentiation factors in general and VIP in particular.J. Mol. Neurosci. 4, 1–9.

    Article  PubMed  CAS  Google Scholar 

  • Gozes Y., Brenneman D. E., Fridkin M., Asofsky R., and Gozes I. (1991) A VIP antagonist distinguishes VIP receptors on spinal cord cells and lymphocytes.Brain Res. 540, 319–321.

    Article  PubMed  CAS  Google Scholar 

  • Gressens P., Hill J. M., Gozes I., Fridkin M., and Brenneman D. E. (1993) Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryos.Nature 362, 155–158.

    Article  PubMed  CAS  Google Scholar 

  • Grider J. R., Murthy K. S., ** J. G., and Makhlouf G. M. (1992) Stimulation of nitric oxide from muscle cells by VIP: prejunctional enhancement of VIP release.Am. J. Physiol. 262, G774-G778.

    PubMed  CAS  Google Scholar 

  • Hachisu M., Hiranuma T., Tani S., and Iizuka T. (1991) Enzymic degradation of helodermin and vasoactive intestinal polypeptide.J. Pharmacobio-Dyn. 14, 126–131.

    PubMed  CAS  Google Scholar 

  • Haegerstrand A., Jonzon B., Dalsgaard C. J., and Nilsson J. (1989) Vasoactive intestinal polypeptide stimulates cell proliferation and adenylate cyclase activity of cultured human keratinocytes.Proc. Natl. Acad. Sci. USA 86, 5993–5996.

    Article  PubMed  CAS  Google Scholar 

  • Hedlund B., Dufy B., and Barker L. (1988) Vasoactive intestinal polypeptide alters GH3/B6 pituitary cell excitability.Pflügers Arch. 411, 173–179.

    Article  PubMed  CAS  Google Scholar 

  • Hill J. M., Harris A., and Hilton-Clarke D. I. (1992) Regional distribution of guanine nucleotide-sensitive and guanine nucleotide-insensitive vasoactive intestinal peptide receptors in rat brain.Neuroscience 48, 925–932.

    Article  PubMed  CAS  Google Scholar 

  • Hill J. M., Agoston, D. V., Gressens P., and McCune S. K. (1994) Distribution of VIP mRNA and two distinct VIP binding sites in the develo** rat brain: relation to ontogenic events.J. Comp. Neurol. 342, 186–205.

    Article  PubMed  CAS  Google Scholar 

  • Hoshino M., Li M., Zheng L. Q., Suzuki M., Mochizuki T., and Yanaihara N. (1993) Pituitary adenylate cyclase activating peptide and vasoactive intestinal polypeptide: differentiation effects on human neuroblastoma NB-OK-1 cells.Neurosci. Lett. 159, 35–38.

    Article  PubMed  CAS  Google Scholar 

  • Hultgardh-Nilsson A., Nilsson J., Jonzon B., and Dalsgaard C. J. (1988) Growth-inhibitory properties of vasoactive intestinal peptide.Regul. Pept. 22, 267–274.

    Article  PubMed  CAS  Google Scholar 

  • Hoosein N. M., Black B. E., and Brattain D. E. (1989) Promotion of differentiation in human colon carcinoma cells by vasoactive intestinal polypeptide.Regul. Pept. 24, 15–26.

    Article  PubMed  CAS  Google Scholar 

  • Ishihara T., Shigemoto R., Mori K., Takahashi K., and Nagata S. (1992) Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide.Neuron 8, 811–819.

    Article  PubMed  CAS  Google Scholar 

  • Ishioka C., Yoshida A., Kimata H., and Mikawa H. (1992) Vasoactive intestinal peptide stimulates immunoglobulin production and growth of human B cells.Clin. Exp. Immunol. 87, 504–508.

    Article  PubMed  CAS  Google Scholar 

  • Itoh N., Obata K., Yanaihara N., and Okamoto H. (1983) Human preprovasoactive intestinal polypeptide contains a novel PHI-27-like peptide, PHM-7.Nature 304, 547–549.

    Article  PubMed  CAS  Google Scholar 

  • Kawatani M., Rutigliano M., and Groat W. C. (1985) Depolarization and muscarinic excitation induced in a sympathetic ganglion by vasoactive intestinal polypeptide.Science 229, 879–881.

    Article  PubMed  CAS  Google Scholar 

  • Kim S. W., Beauchamp R. D., Townsend C. M. Jr., and Thompson J. C. (1991) Vasoactive intestinal polypeptide inhibitsc-myc expression and growth of human gastric carcinoma cells.Surgery 110, 270–276.

    PubMed  CAS  Google Scholar 

  • Laburthe M. and Couvineau A. (1988) Molecular analysis of vasoactive intestinal peptide receptors.Ann. NY Acad. Sci. 527, 296–313.

    Article  PubMed  CAS  Google Scholar 

  • Lam K. S., Srivasta G., Lechan R. M., Lee, T., and Reichlin S. (1990) Estrogen regulates the gene expression of vasoactive intestinal peptide in the anterior pituitary.Neuroendocrinology 52, 417–421.

    PubMed  CAS  Google Scholar 

  • Lasater E. M., Watling K. J., and Dowling J. E. (1983) Vasoactive intestinal peptide alters membrane potential and cyclic nucleotide levels in retinal horizontal cells.Science 221, 1070–1072,

    Article  PubMed  CAS  Google Scholar 

  • Li M., Hoshino M., and Yanaihara N. (1992) Isolation of large VIP-related peptides in human neuroblastoma.Biomed. Res. 13 S2, 47–50.

    Google Scholar 

  • Lilly C. M., Stamler J. S., Gaston B., Meckel C., Loscalzo J., and Drazen J. M. (1993) Modulation of vasoactive intestinal peptide pulmonary relaxation by NO in tracheally superfused guinea pig lungs.Am. J. Physiol. 265, L410-L415.

    PubMed  CAS  Google Scholar 

  • Luine V. N., Rostene W., Rhodes J., and McEwen B. S. (1984) Activation of choline acetyl transferase by vasoactive intestinal peptide.J. Neurochem. 42, 1131–1134.

    Article  PubMed  CAS  Google Scholar 

  • Luis J., Muller J. M., Abadie B., Martin J. M., Marvaldi J., and Pichon J. (1986) Cycle of the vasoactive intestinal peptide and its binding site in a human adenocarcinoma cell line (HT29).Eur. J. Biochem. 156, 631–636.

    Article  PubMed  CAS  Google Scholar 

  • Luis J., Martin J. M., El Battari A., Marvaldi J., and Pichon J. (1988) The vasoactive intestinal peptide (VIP) receptor: recent data and hypothesis.Biochimie 70, 1311–1322.

    Article  PubMed  CAS  Google Scholar 

  • Lundberg J. M., Hedlund B., and Bartfai T. (1982) Vasoactive intestinal polypeptide enhances muscarinic ligand binding in cat submandibular salivary gland.Nature 295, 147–149.

    Article  PubMed  CAS  Google Scholar 

  • Lutz E. M., Sheward W. J., West K. M., Morrow J. A., Fink G., and Harmar A. J. (1993) The VIP2 receptor: molecular characterization of a cDNA encoding a novel receptor for vasoactive intestinal peptide.FEBS Lett. 334, 3–8.

    Article  PubMed  CAS  Google Scholar 

  • Magistretti P. J., Morrison J. H., Shoemaker W. J., Sapin V., and Bloom F. E. (1981) Vasoactive intestinal polypeptide induces glycogenolysis in mouse cortical slices: a possible regulatory mechanism for the local control of energy metabolism.Proc. Natl. Acad. Sci. USA 78, 6535–6539.

    Article  PubMed  CAS  Google Scholar 

  • Magistretti P. J. (1988) Regulation of glycogenolysis by neurotransmitters in the central nervous system.Diabetes Metab. 14, 237–246.

    CAS  Google Scholar 

  • Malhotra R. K., Wakade T. D., and Wakade A. R. (1988) Vasoactive intestinal polypeptide and muscarine mobilize intracellular Ca2+ through breakdown of phosphoinositides to induce catecholamine secretion.J. Biol. Chem. 263, 2123–2126.

    PubMed  CAS  Google Scholar 

  • Marchis-Mouren G., Martin J. M., Luis J., El Battari A., Muller J. M., Marvaldi J., et al. (1988) HT29, a model cell line: stimulation by the vasoactive intestinal peptide (VIP); VIP receptor structure and metabolism.Biochimie 70, 663–667.

    Article  PubMed  CAS  Google Scholar 

  • Maruno K. and Said S. I. (1992) Vasoactive intestinal peptide inhibits the proliferation of human small cell lung carcinoma.Biomed. Res. 13 S2, 373–376.

    Google Scholar 

  • Maruno K. and Said S. I. (1993) Small-cell lung carcinoma: inhibition of proliferation by vasoactive intestinal peptide and helodermin and enhancement of inhibition by anti-bombesin antibody.Life Sci. 52, 267–271.

    Article  Google Scholar 

  • Meunier A. C., Voisin P., Van Camp G., Cenatiempo Y., and Muller J. M. (1991) Molecular characterization and peptide specificity of two vasoactive intestinal peptide (VIP) binding sites in the chicken pineal.Neuropeptides 19, 1–8.

    Article  PubMed  CAS  Google Scholar 

  • Meunier A. C., Carretier M., El Battari A., Luis J., Karamanos Y., and Muller J. M. (1992) Characterization of the human liver vasoactive intestinal peptide (VIP) receptor.Biomed. Res. 13 S2, 157–162.

    Google Scholar 

  • Misbahuddin M., Oka M., Nakanishi A., and Morita K. (1988) Stimulatory effect of vasoactive intestinal polypeptide on catecholamine secretion from isolated guinea pig adrenal chromaffin cells.Neurosci. Lett. 92, 202–206.

    Article  PubMed  CAS  Google Scholar 

  • Misbin R. I., Wolfe M. M., Morris P., Buynitzky S. J., and McGuigan J. E. (1982) Uptake of vasoactive intestinal peptide by rat liver.Am. J. Physiol. 243, G103-G111.

    PubMed  CAS  Google Scholar 

  • Moody T. W., Zia F., Goldstein A. L., Naylor P. H., Sarin E., Brenneman D., et al. (1992) VIP analogues inhibit small cell lung cancer growth.Biomed. Res. 13 S2, 131–136.

    Google Scholar 

  • Muller J. M., El Battari A., Ah-Kye E., Luis J., Ducret F., Pichon J., et al. (1985) Internalization of vasoactive intestinal peptide (VIP) in a human adenocarcinoma cell line (HT29).Eur. J. Biochem. 152, 107–114.

    Article  PubMed  CAS  Google Scholar 

  • Muller J. M., Lolait S. J., Yu V. C., Sadee W., and Waschek J. A. (1989) Functional receptors in human neuroblastoma subclones that express VIP precursor mRNA and release VIP-like substances.J. Biol. Chem. 264, 3647–3650.

    PubMed  CAS  Google Scholar 

  • Murthy K. S., Zhang K. M., ** J. G., Grider J. R., and Makhlouf G. M. (1993) VIP-mediated G protein-coupled Ca2+ influx activates a constitutive NOS in dispersed gastric muscle cells.Am. J. Physiol. 265, G660-G671.

    PubMed  CAS  Google Scholar 

  • Nagy G., Mulchaney J. J., and Neill J. D. (1988) Autocrine control of prolactin secretion by vasoactive intestinal peptide.Endocrinology 122, 364–366.

    PubMed  CAS  Google Scholar 

  • O'Dorisio S. M., Fleshmann D. J., Qualman S. J., and O'Dorisio T. M. (1992) Vasoactive intestinal peptide: autocrine growth factor in neuroblastoma.Regul. Pept. 37, 213–226.

    Article  PubMed  Google Scholar 

  • Ohisalo J. J. (1987) Regulatory functions of adenosine.Med. Biol. 65, 181–191.

    PubMed  CAS  Google Scholar 

  • Okamoto S., Okamura H., Miyake M., Takahashi Y., Takagai S., Akagi Y., et al. (1991) Adiurnal variation of vasoactive intestinal peptide (VIP) mRNA under a daily light-dark cycle in the rat suprachiasmatic nucleus.Histochemistry 95, 525–528.

    Article  PubMed  CAS  Google Scholar 

  • Olah Z., Lehel C., Anderson W. B., Brenneman D. E., and Agoston D. V. (1994) Subnanomolar concentration of VIP induces the nuclear translocation of protein kinase C in neonatal rat cortical astrocytes.J. Neurosci. Res. 39, 355–363.

    Article  PubMed  CAS  Google Scholar 

  • Omary M. B. and Kagnoff M. F. (1987) Identification of nuclear receptors for VIP on a human colonic adenocarcinoma cell line.Science 238, 1578–1581.

    Article  PubMed  CAS  Google Scholar 

  • Ottaway C. A. (1987) Selective effects of vasoactive intestinal peptide on the mitogenic response of murine T cells.Immunology 62, 291–297.

    PubMed  CAS  Google Scholar 

  • Paul S. and Ebadi M. (1993) Vasoactive intestinal peptide: its interaction with calmodulin and catalyic antibodies.Neurochem. Int. 23, 197–214.

    Article  PubMed  CAS  Google Scholar 

  • Pincus D. W., DiCicco-Bloom E. M., and Black I. B. (1990) Vasoactive intestinal peptide regulation of neuroblast mitosis and survival: role of cAMP.Brain Res. 514, 355–357.

    Article  PubMed  CAS  Google Scholar 

  • Rathbone M. P., Middlemiss P. J., Kim J. K., Gysbers J. W., DeForge S. P., Smith R. W., et al. (1992) Adenosine and its nucleotides stimulate proliferation of chick astrocytes and human astrocytoma cells.Neurosci. Res. 13, 1–17.

    Article  PubMed  CAS  Google Scholar 

  • Reichlin S. (1988) Neuroendocrine significance of vasoactive intestinal polypeptide.Ann. NY Acad. Sci. 527, 431–449.

    Article  PubMed  CAS  Google Scholar 

  • Romualdi P., Lesa G., Donati A., Balboni G., Tomatis R., and Ferri S. (1992) Alterations in vasoactive intestinal polypeptide related peptides after pentylenetetrazole-induced seizures in rat brain.Eur. J. Pharmacol. 229, 149–153.

    Article  PubMed  CAS  Google Scholar 

  • Rostene W. H. (1984) Neurobiological and neuroendocrine functions of vasoactive intestinal peptide (VIP).Prog. Neurobiol. 22, 103–129.

    Article  PubMed  CAS  Google Scholar 

  • Said S. I. and Mutt V. (1970) Polypeptide with broad biological activity: isolation from small intestine.Science 169, 1217,1218.

    Article  Google Scholar 

  • Said S. I. and Rosenberg R. N. (1976) Vasoactive intestinal polypeptide: abundant immunoreactivity in neural cell lines and normal nervous tissue.Science 192, 907,908.

    Article  Google Scholar 

  • Said S. I. (1986) Vasoactive intestinal peptide.J. Endocrinol. Inves. 9, 191–200.

    CAS  Google Scholar 

  • Said S. I. (1990) Neuropeptides as modulators of injury and inflammation.Life Sci. 47, PL19-PL21.

    Article  PubMed  CAS  Google Scholar 

  • Said S. I. (1991) Vasoactive intestinal polypeptide, biologic role in health and disease (1991)Trends Endocrinol. Metab. 2, 107–112.

    Article  CAS  PubMed  Google Scholar 

  • Said S. I. (1993) Vasoactive intestinal peptide: involvement of calmodulin and catalytic antibodies.Neurochem. Int. 23, 215–219.

    Article  PubMed  CAS  Google Scholar 

  • Schaffer M. M., Carney D. N., Korman L. Y., Lebovic G. S., and Moody T. W. (1987) High affinity binding of VIP to human lung cancer cell lines.Peptides 8, 1101–1106.

    Article  Google Scholar 

  • Shivers B. D., Görcs T. J., Gottschall P. E., and Arimura A. (1991) Two high affinity binding sites for pituitary adenylate cyclase activating polypeptide have different tissue distributions.Endocrinology 128, 3055–3065.

    Article  PubMed  CAS  Google Scholar 

  • Segre G. V. and Goldring R. (1993) Receptors for secretin, calcitonin, parathyroid hormone (PTH)/PTH-related peptide, vasoactive intestinal peptide, glucagon-like peptide I, growth hormone-releasing hormone, and glucagon belong to a new discovered G-protein-linked receptor family.Trends Endocrinol. Metab. 4, 309–314.

    Article  CAS  PubMed  Google Scholar 

  • Stone T. (1991)Neuroscience Perspectives, Adenosine in the Nervous System, Academic, London.

    Google Scholar 

  • Takahashi K., Nakanishi S., and Imamura S. (1993) Direct effects of cutaneous neuropeptides on adenylyl cyclase activity and proliferation in a keratinocyte cell line: stimulation of cyclic AMP formation by CGRP and VIP/PHM, and inhibition by NPY through G protein-coupled receptors.J. Invest. Dermatol. 101, 646–651.

    Article  PubMed  CAS  Google Scholar 

  • Takahashi Y., Ohsawa K., Nishizawa M., Inoue C., Gotoh E., Yanaihara N., et al. (1988) Complete nucleotide sequence of human vasoactive intestinal peptide/PHM-27 gene and its inducible promoter.Ann. NY Acad. Sci. 527, 87–102.

    Article  Google Scholar 

  • Tapia-Arancibia L. and Reichlin S. (1985) Vasoactive intestinal peptide and PHI stimulate somatostatin release from rat cerebral cortical-dien-cephalic cells in dispersed culture.Brain Res. 336, 67–72.

    Article  PubMed  CAS  Google Scholar 

  • Tatemoto K., Jörnvall H., McDonald T. J., Carlquist M., Go V. L. W., Johansson C., et al. (1984) Isolation and primary structure of human PHI (peptide HI).FEBS Lett. 174, 258–261.

    Article  PubMed  CAS  Google Scholar 

  • Tatsuno I., Yada T., Vigh S., Hidaka, H., and Arimura A. (1992) Pituitary adenylate cyclase activating polypeptide and vasoactive intestinal peptide cytosolic free calcium concentrations in cultured rat hippocampal neurons.Endocrinology 131, 73–81.

    Article  PubMed  CAS  Google Scholar 

  • Tey H. B., Khoo H. E., and Tan C. H. (1992) Adenosine modulates cell growth in human epidermoid carcinoma (A431) cells.Biochem. Biophys. Res. Commun. 187, 1486–1492.

    Article  PubMed  CAS  Google Scholar 

  • Trotz M. E. and Said S. I. (1993) Vasoactive intestinal peptide and helodermin inhibit phospholipase A2 activity in vitro.Regul. Pept. 48, 301–307.

    Article  PubMed  CAS  Google Scholar 

  • Turner J. T., Jones S. B., and Bylund D. B. (1986) A fragment of vasoactive intestinal peptide, VIP (10–28) is an antagonist of VIP in the colon carcinoma cell line HT29.Peptides 7, 849–854.

    Article  PubMed  CAS  Google Scholar 

  • Waelbroeck M., Robberecht P., Coy D. H., Camus J. C., De Neef P., and Christophe J. (1985) Interaction of growth releasing factor (GRF) and 14 GRF analogs with vasoactive intestinal peptide (VIP) receptors of rat pancreas. Discovery of (N-Ac-Tyr1, D-Phe2)-GRF (1–29)-NH2 as a VIP antagonist.Endocrinology 116, 2643–2649.

    PubMed  CAS  Google Scholar 

  • Waschek J. A. and Eiden L. E. (1988) Calcium requirements for barium stimulation of enkephalin and vasoactive intestinal peptide biosynthesis in adrenomedullary chromaffin cells.Neuropeptides 11, 39–45.

    Article  PubMed  CAS  Google Scholar 

  • Waschek J. A., Hsu C. M., and Eiden L. E. (1988) Lineage-specific regulation of the vasoactive intestinal peptide gene in neuroblastoma cells is conferred by 5.2 kilobases of 5′-flanquing sequence.Proc. Natl. Acad. Sci. USA 85, 9547–9551.

    Article  PubMed  CAS  Google Scholar 

  • Waschek J. A., Muller J. M., Duan D. S., and Sadee W. (1989) Retinoic acid enhances VIP receptor expression and responsiveness in human neuroblastoma cells, SH-SY5Y.FEBS Lett. 250, 611–618.

    Article  PubMed  CAS  Google Scholar 

  • Waschek J. A., Krajniak K. G., Bravo D. T., and Agoston D. V. (1992) Regulation of the human and mouse vasoactive intestinal peptide (VIP) genes.Biomed. Res. 13 S2, 1–6.

    Google Scholar 

  • Wei E. T. and Thomas H. A. (1993) Anti-inflammatory peptide agonists.Ann. Rev. Pharmacol. Toxicol. 33, 91–108.

    CAS  Google Scholar 

  • Wollman Y., Lilling G., Goldstein M. N., and Gozes I. (1993) Vasoactive intestinal peptide: a growth promotor in neuroblastoma cells.Brain Res. 624, 339–341.

    Article  PubMed  CAS  Google Scholar 

  • Yamaguchi K., Abe K., and Yanaihara N. (1992) Production of VIP and related peptides in neuroendocrine tumors.Biomed. Res. 13 S2, 279–286.

    Google Scholar 

  • Yu D., Seitz P. K., Selvanayagam P., Rajaraman S., Townsend C. M. Jr., and Cooper C. W. (1992) Effects of vasoactive intestinal peptide on adenosine 3′, 5′-monophosphate, ornithine decarboxylase, and cell growth in a human colon cell line.Endocrinology 131, 1188–1194.

    Article  PubMed  CAS  Google Scholar 

  • Zheng J., Chen Y. F., Cai L. M., Wang D. T., and Liu T. H. (1992) Ontogeny of vasoactive intestinal peptide (VIP) and receptors in human fetal tissues.Biomed. Res. 13 S2, 217–222.

    Google Scholar 

  • Zorn N. E. and Russell D. H. (1990) Vasoactive intestinal peptide (VIP) activation of nuclear protein kinase C in purified nuclei of rat splenocytes.Biochem. Pharmacol. 40 (12), 2689–2694.

    Article  PubMed  CAS  Google Scholar 

  • Zurier R. B., Kozma M., Sinnett-Smth J., and Rozengurt E. (1988) Vasoactive intestinal peptide synergistically stimulate DNA synthesis in mouse 3T3 cells: role of cAMP, Ca2+ and protein kinase C.Exp. Cell Res. 176, 155–161.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratoire de Biologie des Interactions Cellulaires, CNRS URA 1869, 40 Avenue du Recteur Pineau, 86022, Poitiers, France

    Jean-Marc Muller, Vincent Lelievre, Laetitia Becq-Giraudon & Annie-Claire Meunier

Authors
  1. Jean-Marc Muller
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vincent Lelievre
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Laetitia Becq-Giraudon
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Annie-Claire Meunier
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Muller, JM., Lelievre, V., Becq-Giraudon, L. et al. VIP as a cell-growth and differentiation neuromodulator role in neurodevelopment. Mol Neurobiol 10, 115–134 (1995). https://doi.org/10.1007/BF02740671

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02740671

Index Entries

Search

Navigation